@thelimbicderm (@thelimbicderm) 's Twitter Profile
@thelimbicderm

@thelimbicderm

The limbic is an independent news site covering clinical and medico-political news that's relevant to Australian dermatologists.

ID: 1050226945030406151

calendar_today11-10-2018 03:29:50

272 Tweet

95 Followers

156 Following

the limbic (@thelimbiconc) 's Twitter Profile Photo

ICYMI: A new prediction model in high-risk #melanoma could have important implications for clinical decision making when considering adjuvant treatment. Melanoma Institute Australia The Lancet Oncology Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfRScolyerMIA thelimbic.com/oncology/melan…

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

REGISTER: thelimbic.com/dermatology/ca… Join us as experts present & discuss real-life cases of chronic plaque psoriasis focusing on defining new treatment goals & using evidence-based knowledge to optimise management of the disease. CPD approved by DermatologyACD A/Prof Sarah Glastras

REGISTER: thelimbic.com/dermatology/ca…
Join us as experts present & discuss real-life cases of chronic plaque psoriasis focusing on defining new treatment goals & using evidence-based knowledge to optimise management of the disease.
CPD approved by <a href="/DermatologyACD/">DermatologyACD</a> 

<a href="/DrSarahGlastras/">A/Prof Sarah Glastras</a>
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

REGISTER: thelimbic.com/dermatology/ca… Gain expert multidisciplinary insights on real-life cases of chronic plaque psoriasis focusing on defining new treatment goals and managing cardio-metabolic risk factors and other comorbidities. CPD approved by DermatologyACD

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

Gender equity is a basic human right and in academic dermatology will help the profession flourish. It’s not an easy fix but there are clear and implementable steps to get there, according to Dedee Murrell JEADV thelimbic.com/dermatology/12…

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

A novel topical pan-JAK inhibitor has been shown effective in chronic hand #eczema, offering an alternative to long-term corticosteroids and addressing an unmet clinical need. The Lancet thelimbic.com/dermatology/to…

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

Interventions to reduce skin cancer in transplant patients need to come from all levels of care. Dr Elsemieke Plasmeijer #SkinCancer2024

Interventions to reduce skin cancer in transplant patients need to come from all levels of care. Dr Elsemieke Plasmeijer #SkinCancer2024
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

Patients who fear the strong inflammatory skin reaction to 5-fluorouracil required to clear actinic keratosis might be swayed by an emerging combination of topical 5-FU and calcipotriol. #SkinCancer2024 thelimbic.com/dermatology/co…

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

The retinoid acitretin is the go-to drug for chemoprophylaxis of keratinocyte carcinoma in solid organ transplant recipients but there are nuances in how to manage dosage and tolerability #SkinCancer2024 thelimbic.com/dermatology/ho…

@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

Happy holidays to our readers and industry partners! Learn more about the limbic's medical news and education offerings here: thelimbic.com/about-us/?utm_…

theskinhospital (@theskinhospital) 's Twitter Profile Photo

#TheSkinHospital is the first in Australia to invest in the new #Nikon #EclipseUi Digital Upright #Microscope. It will be used for a wide range of purposes.   #dermatology #dermatologists #clinicaltrials #research #dermatologytraining #Abacusdx #dermatologyimaging #registrars

#TheSkinHospital is the first in Australia to invest in the new #Nikon #EclipseUi Digital Upright #Microscope. It will be used for a wide range of purposes. 
 
#dermatology #dermatologists #clinicaltrials #research #dermatologytraining #Abacusdx #dermatologyimaging #registrars
UQ Centre for Health Services Research (@uq_chsr) 's Twitter Profile Photo

Congratulations to our own Professor David Johnson, awarded an L3 Investigator Grant for improving kidney failure care accessibility, affordability, quality and outcomes, and enabling continued leadership of the Australasian AKTN Network.

Congratulations to our own Professor David Johnson, awarded an L3 Investigator Grant for improving kidney failure care accessibility, affordability, quality and outcomes, and enabling continued leadership of the Australasian <a href="/Kidney_Trials/">AKTN</a> Network.
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

REGISTER: thelimbic.com/dermatology/aa… Couldn't make it to #AAD2025 this year? Join our upcoming webinar for an expert discussion on the transformational clinical data presented at the congress and its implications for your practice. CPD approved: DermatologyACD

REGISTER: thelimbic.com/dermatology/aa…
Couldn't make it to #AAD2025 this year? Join our upcoming webinar for an expert discussion on the transformational clinical data presented at the congress and its implications for your practice.
CPD approved: <a href="/DermatologyACD/">DermatologyACD</a>
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

REGISTER: thelimbic.com/dermatology/ea… Thursday - join online as experts present their selection of transformational clinical data from the @eadv 2025 Annual Congress and discuss the impacts for Australian clinical practice. CPD approved by DermatologyACD

REGISTER: thelimbic.com/dermatology/ea…
Thursday - join online as experts present their selection of transformational clinical data from the @eadv 2025 Annual Congress and discuss the impacts for Australian clinical practice.
CPD approved by <a href="/DermatologyACD/">DermatologyACD</a>
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

REGISTER: thelimbic.com/dermatology/ke… Join an expert-led session on the advances in management & treatment of hidradenitis suppurativa with an overview of new Australasian guidelines, real-world case studies & new data on novel therapies. CPD approved DermatologyACD Pablo Fernandez-Peñas

REGISTER: thelimbic.com/dermatology/ke…
Join an expert-led session on the advances in management &amp; treatment of hidradenitis suppurativa with an overview of new Australasian guidelines, real-world case studies &amp; new data on novel therapies.
CPD approved <a href="/DermatologyACD/">DermatologyACD</a> 
<a href="/PabloFP_Syd/">Pablo Fernandez-Peñas</a>
@thelimbicderm (@thelimbicderm) 's Twitter Profile Photo

Watch the webinar: thelimbic.com/dermatology/on… Missed our webinar on the latest advances in the management and treatment of hidradenitis suppurativa? Here's an overview of the topics discussed in this insightful expert-led session. Pablo Fernandez-Peñas, DermatologyACD